Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,134.31
(
0.35%
)
US TECH 100
25,985.80
(
0.44%
)
Dow Jones
49,788.86
(
0.69%
)
Brent Oil
91.97
(
1.42%
)
Bitcoin
76,179.50
(
0.38%
)
News Focus
News Focus
Post# of 257432
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Fred Kadiddlehopper post# 252725

Tuesday, 11/12/2024 1:06:24 PM

Tuesday, November 12, 2024 1:06:24 PM

Post# of 257432
MYNZ +27% on TMO development/commercialization deal—no financial terms disclosed:

https://www.globenewswire.com/news-release/2024/11/12/2979299/0/en/Mainz-Biomed-and-Thermo-Fisher-Scientific-Sign-a-Collaboration-Agreement-for-the-Development-of-Next-Generation-Colorectal-Cancer-Screening-Product-for-Global-Markets.html

The collaboration agreement will enable Mainz Biomed and Thermo Fisher to jointly develop and potentially commercialize Mainz Biomed’s Next Generation colorectal cancer screening product. The collaboration will harness Thermo Fisher’s powerful technologies, instrumentation and information translation systems to enable Mainz Biomed to develop the proprietary assays for its mRNA-based next-generation CRC screening tests…

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today